PMID: 15220215Jun 29, 2004Paper

A 212-kb region on chromosome 6q25 containing the TAB2 gene is associated with susceptibility to type 1 diabetes

Diabetes
D OwerbachKenneth H Gabbay

Abstract

The IDDM5 gene, which is identified by whole-genome searches, is located on chromosome 6q25. TAB2 (MAP3K7IP2 [mitogen-activating protein kinase kinase kinase 7 interacting protein 2]) is a potential candidate gene for type 1 diabetes because it is located on chromosome 6q25 and is involved in nuclear factor (NF)-kappaB regulation. We have conducted familial association studies using 478 families and demonstrate that a type 1 diabetes susceptibility gene resides within a 212-kb region containing the TAB2 gene (Tsp = 1.0 x 10(-2) to 4.0 x 10(-4)). No amino acid polymorphisms were detected in TAB2; however, multiple single nucleotide polymorphisms (SNPs) found within 5' untranslated, 3' untranslated, and intron regions were associated with type 1 diabetes susceptibility. Two additional genes, LOC340152, a predicted gene with currently unknown function, and SMT3, which has homology to SUMO (small ubiquitin-related modifier) were found within the 212-kb region and were associated with type 1 diabetes susceptibility. Functional studies of the three genes will be required to determine their biological relevance to type 1 diabetes. However, both TAB2 and SUMO are involved in NF-kappaB activation and may thus be involved in type 1 diabe...Continue Reading

References

Aug 1, 1997·American Journal of Human Genetics·E R MartinB S Weir
Nov 24, 1999·Molecular and Cellular Biology·T Hayashi, D Faustman
Mar 27, 2001·Nature Reviews. Molecular Cell Biology·S MüllerS Jentsch
May 2, 2002·Cell·Sankar Ghosh, Michael Karin
Jan 31, 2003·Molecular and Cellular Biology·Hideki SanjoShizuo Akira

❮ Previous
Next ❯

Citations

Apr 5, 2005·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Manyu LiCong-Yi Wang
Sep 17, 2008·The Review of Diabetic Studies : RDS·Hiroshi IkegamiYumiko Kawabata
Feb 27, 2007·Vascular Health and Risk Management·Catherine A SchnabelOrville Kolterman
May 8, 2009·Internal Medicine·Keiichiro MatobaNaoko Tajima
May 19, 2010·Biomarkers in Medicine·Neeraj KumarNarinder Mehra
Feb 25, 2005·Genes and Immunity·R Kosoy, P Concannon
Apr 11, 2012·Canadian Journal of Physiology and Pharmacology·Jocelyn E Manning FoxPatrick E Macdonald
Apr 25, 2007·Diabetes Research and Clinical Practice·Hiroshi IkegamiToshio Ogihara
Apr 29, 2005·Diabetes/metabolism Research and Reviews
Nov 9, 2007·Diabetes/metabolism Research and Reviews·Cong-Yi Wang, Jin-Xiong She
Nov 30, 2006·Annals of the New York Academy of Sciences·Hiroshi IkegamiToshio Ogihara
Nov 30, 2006·Annals of the New York Academy of Sciences·Cong-Yi WangJin-Xiong She
Nov 30, 2006·Annals of the New York Academy of Sciences·Shinsuke NosoToshio Ogihara
Sep 24, 2004·Biochemical and Biophysical Research Communications·David OwerbachKenneth H Gabbay
Jan 18, 2006·Trends in Molecular Medicine·Simon H S Pearce, Tony R Merriman
Nov 3, 2005·Journal of Autoimmunity·Suna Onengut-Gumuscu, Patrick Concannon
Oct 4, 2005·Biochemical and Biophysical Research Communications·David OwerbachKurt M Bohren
Dec 13, 2005·Molecular and Cellular Biochemistry·Muthuswamy BalasubramanyamViswanathan Mohan

❮ Previous
Next ❯

Related Concepts

Related Feeds

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis